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Abstract
Background: Carpal tunnel syndrome is a common disorder in hand surgery practice. Both surgical and
conservative interventions are utilized for the carpal tunnel syndrome. Although certain indications would
specifically indicate the need for surgery, there is a spectrum of patients for whom either treatment option might
be selected. The purpose of this systematic review was to compare the efficacy of surgical treatment of carpal
tunnel syndrome with conservative treatment
Methods: We included all controlled trials written in English, attempting to compare any surgical interventions
with any conservative therapies. We searched Cochrane Central Register of Controlled Trials (The Cochrane Library
Issue 1, 2010), MEDLINE (1980 to June 2010), EMBASE (1980 to June 2010), PEDro (searched in June 2010),
international guidelines, computer searches based on key words and reference lists of articles. Two reviewers
performed study selection, assessment of methodological quality and data extraction independently of each other.
Weighted mean differences and 95% confidence intervals for patient self-reported functional and symptom
questionnaires were calculated. Relative risk (RR) and 95% confidence intervals for electrophysiological studies and
complication were also calculated.
Results: We assessed seven studies in this review including 5 RCTs and 2 controlled trials. The methodological
quality of the trials ranged from moderate to high. The weighted mean difference demonstrated a larger treatment
benefit for surgical intervention compared to non surgical intervention at six months for functional status 0.35(
95% CI 0.22, 0.47) and symptom severity 0.43 (95% CI 0.29, 0.57). There were no statistically significant difference
between the intervention options at 3 months but there was a benefit in favor of surgery in terms of function and
symptom relief at 12 months ( 0.35, 95% CI 0.15, 0.55 and 0.37, 95% CI 0.19 to 0.56). The RR for secondary
outcomes of normal nerve conduction studies was 2.3 (95% CI 1.2, 4.4), while RR was 2.03 (95% CI 1.28 to 3.22) for
complication, both favoring surgery.
Conclusion: Both surgical and conservative interventions had treatment benefit in carpal tunnel syndrome.
Surgical treatment has a superior benefit, in symptoms and function, at six and twelve months. Patient underwent
surgical release were two times more likely to have normal nerve conduction studies but also had complication
and side effects as well. Given the treatment differential and potential for adverse effects and that conservative
interventions benefitted a substantial proportion of patients, current practice of a trial of conservative management
with surgical release for severe or persistent symptoms is supported by evidence.
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Carpal tunnel syndrome (CTS) is the most common
entrapment neuropathy [1] in America. The prevalence of
CTS is from 1% to 3% [2,3]; with an incidence that peaks
in the late 50s [4]. There is a high rate of CTS within cer-
tain occupational groups such as meatpackers, poultry
processors and automobile assembly workers [5] which is
attributed to job tasks that require intensive manual exer-
tion. In addition, CTS is associated with some systemic
conditions, such as rheumatoid arthritis, hypothyroidism,
diabetes mellitus, gout, and pregnancy [6]. Both conserva-
tive and surgical treatments are used to manage CTS. The
non-surgical treatment options include splinting, steroids,
activity modification, non-steroidal anti-inflammatory
drugs, diuretics, vitamin B-6 and others. However, of the
conservative approaches only splinting [7] and steroids [8]
are supported by high quality evidence.
Surgical release of the carpal tunnel is known to be
effective and is typically used for patients who fail to
achieve adequate relief with conservative managements
and for those with moderate to severe symptoms [9].
Although surgical intervention is considered as the defi-
nitive treatment to the CTS, it is not considered a first
line of treatment. Conservative intervention may not be
curative; but may provide sufficient relief in a propor-
tion of cases. It may also be a patient preference due to
concerns about the discomfort, inconvenience or safety
of surgery. Conservative management is typically pre-
ferred for transient cases of CTS such as those asso-
ciated with pregnancy or short-term overuse. In other
cases conservative management might be used for par-
tial relief of symptoms while awaiting surgery or for
diagnostic purposes in determining patient response.
Despite, potential variations in indications for one treat-
ment and the associated expectations, there are a sub-
stantial proportion of patients for whom conservative
management may have provided incomplete relief.
These patients require evidence that surgical interven-
tion has is more effective to proceed to surgery.
Systematic reviews provided the best evidence. In
2008, Verdugo et al. [7] conducted a systematic review
comparing surgical and non-surgical treatment for CTS;
were able to locate four randomized controlled trials.
The objective of this study was to build on this work by
adopting boarder inclusion criterion, locating more
recent trials that conducting a meta-analysis to synthe-
size evidence in a more quantitative manner.
Methods
Literature search
A literature search of four databases was conducted in
June 2010 for studies addressing effectiveness of surgical
or conservative interventions for CTS. The research
strategy is list in Additional File 1.
These databases were Cochrane Central Register of
Controlled Trials (CENTRAL) (The Cochrane Library
Issue 1, 2010), MEDLINE (1980 to June 2010), EMBASE
(1980 to June 2010), PEDro (searched in June 2010).
Only English language papers were included. Searching
of international guidelines, computer searches based on
key words, and hand searching for references from pre-
viously retrieved articles was used to extend the search
strategy.
Research articles were included for review if they met
the following criteria:
1. The study was written in English.
2. The study was designed as a prospective controlled
trial.
3. The study subjects/patients had a diagnosis of CTS,
irrespective of the diagnostic criteria used, etiology of
the syndrome, associated pathology, gender and age.
4. The study compared any surgical with non-surgical
intervention.
The surgical treatments include:
1. Standard open carpal tunnel release (OCTR).
2. Endoscopic carpal tunnel release (ECTR).
3. Open carpal tunnel release with additional proce-
dures such as internal neurolysis, epineurotomy or
tenosynovectomy.
4. Open carpal tunnel release using various incision
techniques.
The non-surgical treatment includes:
1. Drugs: oral or local steroids, non-steroidal anti-
inflammatory drugs (NSAIDs), diuretics, pyridoxine, etc.
2. Wrist splints.
3. Physical therapy, therapeutic exercises and manipu-
lations. (ultrasound, laser therapy, yoga, and acupunc-
ture, etc).
Research articles were excluded from review if they
met the following criteria:
1. The study investigated the efficacy of two surgical
interventions or two non-surgical managements.
2. The study did not provide data on intervention
effectiveness).
3. The study published before 1970.
Types of outcome measures
Primary outcome:
The primary outcome measure was patient self-
reported functional and symptoms improvement at six
months of follow-up. We selected this time point
because most studies discussed the post operative status
6 months after the intervention.
Secondary outcomes:
1. Patient self-reported functional and symptoms
improvement at three months of follow-up.
2. Patient self-reported functional and symptoms
improvement at twelve months of follow-up.
Shi and MacDermid Journal of Orthopaedic Surgery and Research 2011, 6:17
http://www.josr-online.com/content/6/1/17
Page 2 of 93. Improvement of neurophysiological parameters.
4. Complications and side-effects.
Data collection
Study authors (QS and JM)) independently performed
the study selection, assessment of methodological qual-
ity and data abstraction. Structured data extraction
forms were used to extract data on the characteristics of
individual studies. Information was collected on partici-
pants (age, sex, diagnostic criteria used to confirm CTS,
severity of symptoms, duration of symptoms, inclusion/
exclusion criteria, trial setting, allocation procedure,
blinding, number of participants or hands randomized),
interventions (description of interventions, treatment
length, number and explanation for any drop-outs) and
outcome measures (description of measures used, con-
tinuous/dichotomous nature). We used the Cohen’s
(unweighted) kappa to assess the agreement between
the two reviewers on study selection.
Validity assessment
All the articles were assessed by two reviewers (QS, JM)
using Jadad et al. scale [10] (see Additional File 2) and
the Structured Effectiveness Quality Evaluation Scale
(SEQES) (see Additional File 3) independently. All the
disagreement was solved by consensus discussion.
Jadad et al. scale is used to assess the methodology
quality of each study. There are 3 criteria for this scale
and total score ranges from 0 to 5. We decided that the
s t u d yw a sh i g hq u a l i t yi ft h ec u m u l a t i v es c o r ew a s3o r
more. To add additional detail on the quality of studies
we also used the SEQES [11]. The scale has 24 items,
scored 2, 1, or 0 based on congruence with specific
descriptors. In this review, each study was ranked as
low, moderate, or high quality based on the cumulative
score (/48) using the following metric:
Low quality: scores 1-16
Moderate quality: scores 17-32
High quality: scores 33-48
Data synthesis
Statistical analysis was performed using Review Manager
(RevMan) version 5.0 [12]. Relative risks (RR) were cal-
culated for dichotomous outcomes and weighted mean
differences (WMD) for continuous outcomes. Studies
were compared for heterogeneity using the Chi-square
statistic (P-value < 0.05 considered statistically signifi-
cant) and an I
2 test ( I
2 >50% considered substantial het-
erogeneity). A fixed- effects model was initially used in
this systematic review. A random-effects model was
applied if heterogeneity existed. We conducted a priori
hypothesis to explain the heterogeneity that might exist
between the studies. The potential sources were: differ-
ence in populations, severity of the disease, duration of
the symptoms, intervention techniques, length of treat-
ment and methodological quality.
Results
Description of included studies
There were 1333 articles identified from the literature
research. Based on the abstracts review, only 10 arti-
cles potentially met the criteria for inclusion in this
systematic review. Of these, 3 were excluded (Addi-
tional File 4) during evaluation of the full article based
on the previously established exclusion criteria. Thus,
seven primary studies [13-19] were included in the
systematic review (Table 1). There was good agree-
ment in the selection of trials (Cohen’su n w e i g h t e d
kappa = 0.79).
We assessed seven studies including 5 RCTs and 2 con-
trolled trials in this review. Overall, three studies com-
pared surgery with steroid injection[16.17.18], two for
surgery versus multi- modality [13,15] one for splinting
[19] and one for laser [14]. There was homogeneity in
entry criteria. The majority of patients enrolled in stu-
dies had clinical diagnosis of CTS confirmed by electro-
diagnostic studies. Those had severe thenar muscle
atrophy were excluded since these cases are not typically
considered appropriate for conservative management.
The methodological features of each study are sum-
marized in additional files 5 and 6. Totally four studies
[13,16,17,19] rank high quality according to Jadad Scale.
Because of lack of appropriate blinding, all the studies
were rated as zero at the criteria of “double blinding”.I n
Demirci et al. and Elwakil et al. articles, there were no
adequate randomization performed so that both studies
got zero in this criteria.
The quality of all studies ranges from 29 to 40/48 using
SEQES. There are two high quality studies evaluated the
multi-modality (SEQES = 35-39), two high quality studies
and one moderate for the steroid (SEQES = 31-38), one
high quality study for the splinting (SEQES = 40), one
moderate for the laser (SEQES = 29). The common
shortcomings of the studies were lack of blinding and
inadequate randomization.
All studies concluded that both surgical and non-sur-
gical intervention were beneficial to patients. However,
there were no consistent outcome measures among
identified studies. Patient self-reported scales,
researcher-assessed subjective impairments, muscle
strength and electrophysiological studies were com-
monly used in these studies. Five studies [13,15,
16,18,19] employed patient self-administered functional
and symptomatic scale questionnaires to evaluate the
effect of the surgery. Although, these questionnaires var-
ied across studies we were able to pool four studies that
included scales for disease specific hand function and
symptom to conduct a meta-analysis.
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One high quality [19] and two moderate quality studies
[15,18] compared surgery and steroid injection and/or
splinting by assessing outcomes using the Boston
Questionnaire [20]. The Boston Questionnaire is a
CTS specific tool for patient to self-report the symp-
tom severity (11 items) and functional status (8 items).
The over-all score is calculated as the mean of all
items which is from 1 to 5. The higher the score is,
the worse the symptom or function is. In previous stu-
dies [20,21], the validity and reliability of Boston Ques-
tionnaire has been tested. One high quality study [13]
compared surgery and splinting with Carpal Tunnel
Syndrome Assessment Questionnaire (CTSAQ) which
is similar to the Boston Questionnaire. CTSAQ
is modified from the Boston Questionnaire which
includes 11 questions for symptom and 9 questions for
function. Also, the reliability and responsiveness of
CTSAQ has been verified [20,22]. Gerritsen’ss t u d y
[19] reported improvement score rather than ending
point score in their outcome assessment. We included
these results in our meta-analysis because they pre-
sented same direction of difference.
Figure 1,2 demonstrates the pooled functional and
symptoms score at 6 months of follow up. We found
that surgical was superior to the non surgical interven-
tion at six months with the weighted mean difference
0.35 (95% CI 0.22, 0.47) for functional status and 0.43
(95% CI 0.29, 0.57) for symptom severity. Figure 3,4,5,6
presented the postoperative status score at 3 and 12
months. There were no statistically significant difference
between surgery and non-surgery with regard to symp-
toms or functional score at 3 months, but there was a
benefit in favor of surgery in terms of function and
symptom relief at 12 months ( 0.35, 95% CI 0.15 to 0.55
and 0.37, 95% CI 0.19 to 0.56).
Electrophysiological studies
Five studies [14,15,17-19]evaluated the electrophysiologi-
cal improvement 6 months after the intervention.
Table 1 Summary of study Characteristics
ID Authors Year Country Design Sample size Inclusion and exclusion criteria Study Quality (Jadad
et al. Scores; SEQES)
1 Jarvik
et al. [13]
2009 USA RCT 116
57( OCTR or ECTR)
59( Multi-modality* )
1. Clinical diagnosis of CTS greater than 2
weeks
2. Confirmed by electrodiagnostic studies
3. In absence of electrodiagnostic criteria,
positive in night pain and flick test
4. Excluded if previous treatment with CTS
release surgery, severe thenar muscle atrophy
3/5
39/48
2 Elwakil
et al. [14]
2007 Egypt Comparative
cohort study
60
30 (OCTR)
30 ( Laser )
Clinical diagnosis of CTS 1/5
29/48
3 Ucan
et al. [15]
2006 Turkey RCT 57
11( OCTR)
23 ( Splinting )
23 ( Splinting + one
dose steroid injection)
1. Mild to moderate clinical diagnosis of CTS
greater than 6 months
2. Confirmed by electrodiagnostic studies
3. Excluded if advanced CTS, thenar atrophy or
previous CTS treatment
2/5
36/48
4 Ly-Pen
et al [16].
2005 Spain RCT 163
80( OCTR)
83 (one or two-dose
steroid injection )
1. Clinical diagnosis of CTS greater than 3
months
2. Confirmed by electrodiagnostic studies
3. Excluded if previous treatment with CTS
release surgery, severe thenar muscle atrophy
3/5
35/48
5 Hui et al.
[17]
2005 Hong Kong RCT 50
25( OCTR)
25 ( One dose steroid
injection )
1. Clinical diagnosis of CTS greater than
3 months but less than 1 year
2. Confirmed by electrodiagnostic studies
3. Excluded if severe thenar muscle atrophy,
ulnar, radial neuropathy
3/5
38/48
6 Demirci
et al. [18]
2002 Turkey Comparative
cohort study
90
44( OCTR)
46 ( Two-dose steroid
injection )
1. Clinical diagnosis of CTS greater than 6
months
2. Confirmed by electrodiagnostic studies
3. Excluded if previous steroid injection, OCTR
or distal radius fracture
0/5
31/48
7 Gerritsen
et al [19]
2002 Netherlands RCT 176
87( OCTR)
89 ( Splinting )
1. Clinical diagnosis of CTS
2. Confirmed by electrodiagnostic studies
3. Excluded if severe thenar muscle atrophy
3/5 40/48
RCT: randomized clinical trials.
OCTR: standard open carpal tunnel release.
ECTR: Endoscopic carpal tunnel release.
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motor nerve distal latency while three moderate quality
studies [14,15,18]assessed the number of normal nerve
conduction tests at 6 months follow up. Surgery was
found to be superior to conservative management
regarding to the improvement of electrophysiological
studies (Figure 7 and 8). For median motor nerve distal
latency, the pooled effect size was 0.5 (95% CI 0.16,
0.85), indicating 50% more patients got normal distal
latency after surgery. The relative risk of having normal
nerve conduction tests after treatment was 2.3 (95% CI
1.2, 4.4), also favoring surgery.
Complication and side effect
Six studies [13-17,19]reported complication and side
effect of surgery and medication intervention (Figure 9).
A number of minor adverse effects were reported
including: painful or hypertrophic scar, stiffness, swelling
or discomfort of the wrist, most of them were resolved
spontaneously in few weeks. Some authors [18] reported
all complication regardless the severity while others only
declared clinically important adverse events. This results
in a large variation across studies in terms of complica-
tion rates. Overall, the pooled relative risk indicated a
higher rate of complications in the surgical group (RR =
2.03, 95% CI 1.28 to 3.22). The most common complica-
tions reported in the surgical group were skin irritation
and wound hematoma; while the complication reported
with splinting was swelling of the wrist, hand and finger.
Discussion
Despite, the limitation in the number of randomized
controlled trials available in current literature, this sys-
tematic review was able to provide evidence that CTS
symptoms improved in both interventions.
All the studies reported that both conservative man-
agements (splinting, steroid and laser therapy) and sur-
gery result in clinically significant improvement in
symptoms. Some authors [13,15,17-19] concluded that
surgical decompression produces long-term systematic
improvement compared with the non-surgical interven-
tion. We found that the positive impact of conservative
management plateaus within 3 months whereas, the
clinical effect of surgical intervention up until 12
th
months after the treatment. The relative advantage of
surgery at 6 months (WMD = 0.35) indicated that
patient with surgical release had approximately 0.35
points lower functional scores than those receiving con-
servative intervention. Although there was a similar
trend at 12 months, no further improvement was
Figure 2 Patient self-reported symptom improvement at 6 months.
Figure 1 Patient self-reported functional improvement at 6 months.
Shi and MacDermid Journal of Orthopaedic Surgery and Research 2011, 6:17
http://www.josr-online.com/content/6/1/17
Page 5 of 9observed at 12 months of follow-up. Thus, the current
treatment approach of providing a conservative manage-
ment as a front-line treatment in mild to moderate
cases before considering surgery is justified.
However, surgery was superior to the non surgical
intervention regarding the improvement of electrophy-
siological study. The relative advantage of surgery (RR =
2.3) indicated that approximately twice as many patients
achieve better outcomes with surgery. This is important
information for patient who fails conservative manage-
ment to understand when deciding whether they should
consent to surgery.
Prognosis was not addressed in these study trials but
others have indicated that patients presenting with
higher symptom severity scores and those not respond-
ing within the first six weeks are more likely to proceed
to surgery following conservative management [23].
Given that the size of the treatment advantage for surgi-
cal management is relatively small, and that improve-
ments are noted with both conservative and surgical
approaches the evidence does not support proceeding
directly to surgery. The presenting symptoms/nerve
damage, response/relief after conservative management,
comorbid issues and patient circumstances/preferences
will determine the optimal decision about surgery.
There are potential complications that patients must
consider, in particular for surgical management or ster-
oid injection. Given the huge variation of how
complications are defined, this systematic review was
not well positioned to determine accurate rates of these
complications.
Our review indicates substantial heterogeneity in
effects between studies. This may have resulted from
variations between the studies in terms of intervention
techniques, length of treatment, methodological quality,
etc. For example, all the patients in splinting group
received 6 weeks treatment in Gerritsen study [19] while
patients in Ucan study [15] used the splinting for
3 months. For this reason future systematic reviews that
included larger numbers of studies might be useful to
differentiate subgroups who would benefit most from
conservative versus surgical management or factors
associated with successful treatment in either treatment
arm.
Critical appraisal of trials involving surgery, or hands-
on interventions within the scope of conservative man-
agement have some inherent challenges in blinding that
affect their scores on most critical appraisal instruments.
W h i l et h eJ a d a ds c a l ei sc o m m o n l yu s e d ,o t h e r sh a v e
pointed out its lack of reliability and validity with
respect to surgery and rehabilitation research [24,25].
For this reason we used a 24-item structured evaluation
instrument [26] that has be e nu s e di no t h e rh a n ds u r -
gery/therapy systematic reviews [27,28]. This instrument
also provides extra credit for blinding, but has an inter-
mediary score for cases where blinding is not possible.
Figure 3 Patient self-reported functional improvement at 3 months.
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Figure 4 Patient self-reported symptom improvement at 3 months.
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Figure 5 Patient self-reported functional improvement at 12 months.
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Figure 6 Patient self-reported symptom improvement at 12 months.
Figure 7 Improvement in distal motor latency at 6 months.
g
Figure 8 Number of normal nerve studies after intervention.
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study in addition to blinding there is an opportunity for
well-designed surgery trials to be favorably rated despite
a lack of blinding.
One limitation of this systematic review is only studies
written in English were included, which might introduce
a publication bias. However, one recent assessment
reported that non-English papers are likely to be of low
quality and could result in bias into a review [29].
Further Research
We observed a small to moderate incremental benefit
in surgical group for patients with carpal tunnel syn-
drome. However, given that conservative management
is effective in relieving symptoms and can circumvent
the need for surgery in a certain proportion of cases it
remains a justified first line treatment. Therefore, we
do not see a need for further trials comparing conser-
vative management versus surgical management but
rather a need for better prognostic studies that would
identify the characteristics of patients most likely to
respond to each type of intervention. This would form
a basis for clinical prediction rules and clearer criteria
for which patients should be fast tracked to surgery
and how long conservative management should be sus-
tained before making decisions about transitioning into
a surgical procedure.
Conclusion
This systematic review presents that both surgical and
conservative interventions are beneficial in the man-
agement of carpal tunnel syndrome. Surgical treatment
provides a better outcome up to twelve months in
terms of symptoms and restoration of normal nerve
conductions test results; but has higher complication
risk. Most complications of CTS interventions are
mild. Since conservative interventions are beneficial for
a substantial proportion of patients and effects plateau
within three months the traditional approach to use
a trial of conservative management in patients with
mild and moderate or transient CTS is supported by
evidence.
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